Wegovy obesity drug sales more than double but set to slow - Sales of Wegovy, a prescription weight loss injection, surged to ...
Novo Nordisk reported Q4 sales of $11.96 billion, beating estimates. The company plans a new phase 3 trial for CagriSema in ...
Novo Nordisk (NVO) said on Wednesday that its emissions rose by nearly a quarter in 2024 and will continue to increase up to ...
Obesity drug maker Novo Nordisk forecast slower growth this year after Wegovy sales more than doubled in the final quarter of ...
The Danish pharmaceutical company’s blockbuster Wegovy weight-loss drug just missed sales expectations in the fourth quarter ...
New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...
But in the Green Bay Packers' last three games, including an ugly season-ending 22-10 loss to the Philadelphia Eagles in the NFC playoffs Sunday, Love hasn't looked like one. Love's average passer ...
Early turnovers, sluggish offense, injuries plague Packers in 22-10 wild-card playoff loss to Eagles
For a team that has appeared to be on the ropes down the stretch, that was essentially ballgame in a 22-10 loss. The Packers never recovered ... in their losses against the NFC’s top teams. The more ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback